|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.055 CAD | 0.00% |
|
+22.22% | +37.50% |
On March 29, 2022, GeneTether Therapeutics Inc. closed the transaction. The transaction included participation from certain insiders for 5,883,824 units. The company raised gross proceeds of CAD 4,500,000 at a price of CAD 0.60 per unit.
Each unit was comprised of one common share in the capital of the company and one common share purchase warrant. Each warrant entitles to acquire one additional common share at an exercise price of CAD 0.72 share until March 29, 2025.
| 1st Jan change | Capi. | |
|---|---|---|
| +37.50% | 1.57M | |
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B |
GENETETHER THERAPEUTICS INC. 
